2SEVENTY BIO INC (TSVT)
US9013841070 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -223.22M | -217.57M | -254.15M | -292.21M | -120.11M | |||
| Depreciation Amortization | 10.13M | 10.29M | 11.53M | 16.35M | 13.19M | |||
| Change In Working Capital | 17.48M | 2.60M | -35.87M | 13.33M | -15.47M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 35.96M | 37.82M | 41.36M | 55.50M | 54.60M | |||
| OPERATING CASH FLOW | -159.65M | -166.86M | -237.13M | -207.03M | -67.79M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -8.40M | -13.87M | -22.84M | -19.58M | -22.26M | |||
| Other Investing Activity | 29.29M | 57.73M | 34.54M | 34.99M | N/A | |||
| INVESTING CASH FLOW | 20.89M | 43.86M | 11.70M | 15.41M | -22.26M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 696.00K | 127.39M | 166.23M | 354.89M | 90.05M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 696.00K | 127.39M | 166.23M | 354.89M | 90.05M | |||
| CHANGE IN CASH | -138.06M | 4.39M | -59.20M | 163.27M | -0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -159.65M | -166.86M | -237.13M | -207.03M | -67.79M | |||
| Capital Expenditure | -8.40M | -13.87M | -22.84M | -19.58M | -22.26M | |||
| FREE CASH FLOW | -168.04M | -180.72M | -259.97M | -226.61M | -90.05M | |||
All data in USD